First-in-Human Study of Mivebresib (ABBV-075), an Oral...

Clinical Cancer Research 2019 / 11 Vol. 25; Iss. 21

First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors

Piha-Paul, Sarina A., Sachdev, Jasgit C., Barve, Minal, LoRusso, Patricia, Szmulewitz, Russell, Patel, Sapna Pradyuman, Lara, Primo N., Chen, Xiaotian, Hu, Beibei, Freise, Kevin J., Modi, Dimple, Sood
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-0578
Date:
November, 2019
File:
PDF, 743 KB
2019
Conversion to is in progress
Conversion to is failed